211 related articles for article (PubMed ID: 19370758)
1. DES in CTO: cosmetic or clinical benefit.
Goyal BK
Catheter Cardiovasc Interv; 2009 May; 73(6):780. PubMed ID: 19370758
[No Abstract] [Full Text] [Related]
2. Angiographic and clinical outcomes of drug-eluting versus bare metal stent deployment in the Occluded Artery Trial.
Dzavík V; Buller CE; Devlin G; Carere RG; Mancini GB; Cantor WJ; Buszman PE; Rankin JM; Vozzi C; Ross JR; Forman S; Barton BA; Lamas AG; Hochman JS
Catheter Cardiovasc Interv; 2009 May; 73(6):771-9. PubMed ID: 19309733
[TBL] [Abstract][Full Text] [Related]
3. Gone but not forgotten: the case for drug-eluting stents in percutaneous revascularization of the chronic coronary total occlusion.
Tcheng JE; Zidar DA
JACC Cardiovasc Interv; 2009 Dec; 2(12):1266-8. PubMed ID: 20129554
[No Abstract] [Full Text] [Related]
4. Drug eluting stents in CTOs: why not?
Vetrovec GW
Catheter Cardiovasc Interv; 2011 Feb; 77(3):333-4. PubMed ID: 21328678
[No Abstract] [Full Text] [Related]
5. Five-year clinical outcomes after coronary stenting of chronic total occlusion using sirolimus-eluting stents: insights from the rapamycin-eluting stent evaluated at Rotterdam Cardiology Hospital-(Research) Registry.
Shen ZJ; García-García HM; Garg S; Onuma Y; Schenkeveld L; van Domburg RT; Serruys PW;
Catheter Cardiovasc Interv; 2009 Dec; 74(7):979-86. PubMed ID: 19753636
[TBL] [Abstract][Full Text] [Related]
6. Does angiographic response to wiring of totally occluded vessels predict outcomes in ST-segment elevation myocardial infarction?
Ambrose JA; Buhari CF
JACC Cardiovasc Interv; 2011 Jan; 4(1):63-5. PubMed ID: 21251630
[No Abstract] [Full Text] [Related]
7. Long-term clinical outcomes of successful versus unsuccessful revascularization with drug-eluting stents for true chronic total occlusion.
Lee SW; Lee JY; Park DW; Kim YH; Yun SC; Kim WJ; Suh J; Cho YH; Lee NH; Kang SJ; Lee CW; Park SW; Park SJ
Catheter Cardiovasc Interv; 2011 Sep; 78(3):346-53. PubMed ID: 21452248
[TBL] [Abstract][Full Text] [Related]
8. 3-year clinical outcome of patients with chronic total occlusion treated with drug-eluting stents.
De Felice F; Fiorilli R; Parma A; Nazzaro M; Musto C; Sbraga F; Caferri G; Violini R
JACC Cardiovasc Interv; 2009 Dec; 2(12):1260-5. PubMed ID: 20129553
[TBL] [Abstract][Full Text] [Related]
9. Drug-eluting stents: safe but not sufficient.
Vogel RA
JACC Cardiovasc Interv; 2009 Jun; 2(6):513-4. PubMed ID: 19539254
[No Abstract] [Full Text] [Related]
10. Paclitaxel-coated balloon with bare-metal stenting in patients with chronic total occlusions in native coronary arteries.
Wöhrle J; Werner GS
Catheter Cardiovasc Interv; 2013 Apr; 81(5):793-9. PubMed ID: 22511572
[TBL] [Abstract][Full Text] [Related]
11. Better results with the new generation bare metal stents.
Vik-Mo H
Scand Cardiovasc J; 2009 Apr; 43(2):84-6. PubMed ID: 19117238
[No Abstract] [Full Text] [Related]
12. Clinical presentation and outcome of patients hospitalized for symptomatic in-stent restenosis treated by percutaneous coronary intervention: comparison between drug-eluting stents and bare-metal stents.
De Labriolle A; Bonello L; Lemesle G; Steinberg DH; Roy P; Xue Z; Kaneshige K; Suddath WO; Satler LF; Kent KM; Pichard AD; Lindsay J; Waksman R
Arch Cardiovasc Dis; 2009 Mar; 102(3):209-17. PubMed ID: 19375675
[TBL] [Abstract][Full Text] [Related]
13. A critical appraisal of the Janus carbostent.
Kornowski R
Catheter Cardiovasc Interv; 2009 Feb; 73(2):249-50. PubMed ID: 19156897
[No Abstract] [Full Text] [Related]
14. Angiographic restenosis and clinical recurrence after sirolimus- and paclitaxel-eluting stent implantation.
Vlaar PJ; Zijlstra F
JACC Cardiovasc Interv; 2009 Aug; 2(8):776-8. PubMed ID: 19695547
[No Abstract] [Full Text] [Related]
15. Comparison between balloon angioplasty and additional coronary stent implantation for the treatment of drug-eluting stent restenosis: 18-month clinical outcomes.
Sardella G; Colantonio R; De Luca L; Conti G; Di Roma A; Mancone M; Canali E; Benedetti G; Fedele F
J Cardiovasc Med (Hagerstown); 2009 Jun; 10(6):469-73. PubMed ID: 19318976
[TBL] [Abstract][Full Text] [Related]
16. Left main and high-risk PCI: what, exactly, is it high risk for?
Safian RD
Catheter Cardiovasc Interv; 2011 Jun; 77(7):952-3. PubMed ID: 21598347
[No Abstract] [Full Text] [Related]
17. New roads, new ruts: lessons from drug-eluting stent restenosis.
Kastrati A; Byrne R
JACC Cardiovasc Interv; 2011 Feb; 4(2):165-7. PubMed ID: 21349454
[No Abstract] [Full Text] [Related]
18. Percutaneous coronary intervention for a right coronary artery stent occlusion using retrograde delivery of a sirolimus-eluting stent via a septal perforator.
Utunomiya M; Katoh O; Nakamura S
Catheter Cardiovasc Interv; 2009 Mar; 73(4):475-80. PubMed ID: 19229979
[TBL] [Abstract][Full Text] [Related]
19. Funneling: enhancing results of small-vessel stenting.
Kaluski E; Gerula C; Randhawa P; Klapholz M
Cardiovasc Revasc Med; 2009; 10(4):255-8. PubMed ID: 19815174
[TBL] [Abstract][Full Text] [Related]
20. Are our patients better off with drug-eluting stents in saphenous vein grafts?
Douglas JS
JACC Cardiovasc Interv; 2009 Nov; 2(11):1113-5. PubMed ID: 19926053
[No Abstract] [Full Text] [Related]
[Next] [New Search]
